Healthcare · Biotechnology
Is CRISPR Therapeutics AG (CRSP) Stock Halal?
Shariah Compliance Across 5 Standards — Live
Shariah Compliance Verdict — 5 Standards
AAOIFI (Shari'ah Standard 21)market-cap basis
cash/MC 50.1% > 30%; impure income 2971.5% > 5%
Dow Jones Islamic Marketmarket-cap basis
impure income 2971.5% > 5%
FTSE Shariah (Yasaar)total-assets basis
cash/assets 89.6% > 33%; AR+cash/assets 89.6% > 50%; impure income 2971.5% > 5%
MSCI Islamictotal-assets basis
cash/assets 89.6% > 33%; AR+cash/assets 89.6% > 70%; impure income 2971.5% > 5%
S&P Shariahmarket-cap basis
impure income 2971.5% > 5%
Live verdicts from the Halal Terminal screening engine, recomputed against the issuer's latest filings.
Plain-English Summary
Fails AAOIFI, DJIM, FTSE, MSCI, S&P on cash/MC 50.1% > AAOIFI 30%; interest/revenue 2971.5% > AAOIFI 5%, DJIM 5%, FTSE 5%, MSCI 5%, S&P 5%; cash/assets 89.6% > FTSE 33%, MSCI 33%.
Business Activity Screen
Business activity is compliant.
Financial Ratios
Interest-bearing debt / market cap
AAOIFI ≤30% · DJIM/S&P <33% (trailing-avg MC)
16.3%
Cash & interest-bearing / market cap
AAOIFI ≤30% of market cap
50.1%
Debt / total assets
FTSE/MSCI <33.33% of total assets
29.1%
Cash & interest-bearing / total assets
FTSE/MSCI <33.33% of total assets
89.6%
Receivables + cash / total assets
FTSE <50% · MSCI ≤70%
89.6%
Interest income / revenue
≤5% across all methodologies
2972.0%
Raw ratios from the latest filings — each methodology applies its own basis and thresholds (see the verdict box above for per-standard outcomes).
Purification
Purification rate: 100.00% of income
The purification rate estimates the share of the company's income attributable to impure sources (primarily interest). Scholars recommend donating that share of any dividends or gains to charity. Use the terminal's purification calculator for exact amounts on your holding.
Balance-Sheet Trajectory (8 Quarters)
| Quarter end | Debt / assets | Cash / assets | Receivables + cash / assets |
|---|---|---|---|
| 2024-06-30 | 9.9% | 85.5% | 85.5% |
| 2024-09-30 | 10.1% | 85.8% | 85.8% |
| 2024-12-31 | 10.0% | 84.9% | 86.0% |
| 2025-03-31 | 10.1% | 85.7% | 85.7% |
| 2025-06-30 | 10.6% | 84.8% | 84.8% |
| 2025-09-30 | 9.4% | 85.3% | 85.3% |
| 2025-12-31 | 9.1% | 87.2% | 87.2% |
| 2026-03-31 | 28.9% | 89.6% | 89.6% |
A stock that has screened comfortably for eight straight quarters is a different story from one that crossed a threshold last quarter — trajectory shows which one this is.
Compliance Watch
2026-03-14 · verdict-relevant (debt issuance)
Frequently Asked Questions
Is CRISPR Therapeutics AG (CRSP) halal to invest in?
CRISPR Therapeutics AG currently screens as non-compliant on the Halal Terminal engine. The verdict is recomputed against the issuer's latest financial filings and all five major methodologies (AAOIFI, DJIM, FTSE, MSCI, S&P) — see the per-standard breakdown above. This is a data-driven application of published standards, not a fatwa.
Is CRSP compliant under AAOIFI?
No — CRSP currently fails AAOIFI screening: cash/MC 50.1% > 30%; impure income 2971.5% > 5%.
Do I need to purify dividends from CRSP?
The current computed purification rate is 100.00% — the share of income attributable to impure sources that scholars recommend donating to charity.
Why do halal screening apps disagree about CRSP?
Different services apply different ratio bases (market capitalization vs total assets), different revenue classifications, and different data vintages. This page shows both AAOIFI readings side by side and classifies revenue segments explicitly so the source of any disagreement is visible.
Related Stocks
Screen Your Full Portfolio
Halal Terminal screens stocks and ETFs across 5 Shariah standards simultaneously — with live ratios, segment-level business income, purification calculations, and Zakat reports.
Disclaimer: This page is for educational and informational purposes only and does not constitute financial or religious advice. Verdicts and figures come from the Halal Terminal screening engine, computed from the issuer's public financial filings and refreshed regularly (last screened 2026-06-11). This is a data-driven application of published Shariah standards — not a fatwa. Consult a qualified Islamic finance scholar or advisor for personalised guidance.